D.A.L. Morgan

6.3k total citations · 1 hit paper
153 papers, 4.0k citations indexed

About

D.A.L. Morgan is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, D.A.L. Morgan has authored 153 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 62 papers in Cancer Research and 26 papers in Surgery. Recurrent topics in D.A.L. Morgan's work include Breast Cancer Treatment Studies (61 papers), Breast Lesions and Carcinomas (20 papers) and Estrogen and related hormone effects (14 papers). D.A.L. Morgan is often cited by papers focused on Breast Cancer Treatment Studies (61 papers), Breast Lesions and Carcinomas (20 papers) and Estrogen and related hormone effects (14 papers). D.A.L. Morgan collaborates with scholars based in United Kingdom, United States and Switzerland. D.A.L. Morgan's co-authors include Ian O. Ellis, R.W. Blamey, Kwok‐Leung Cheung, Roger Dale, Patrick J. Bradley, Stewart G. Martin, C. Deehan, Bleddyn Jones, Emad A. Rakha and C.W. Elston and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

D.A.L. Morgan

145 papers receiving 3.8k citations

Hit Papers

Total meniscectomy in ado... 2000 2026 2008 2017 2000 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D.A.L. Morgan 1.5k 1.4k 1.4k 758 716 153 4.0k
Madeline Bauer 2.8k 1.9× 1.8k 1.3× 2.0k 1.4× 1.7k 2.2× 892 1.2× 48 5.6k
Michael Schaapveld 1.1k 0.7× 2.2k 1.5× 1.2k 0.9× 1.4k 1.8× 1.2k 1.7× 155 5.7k
Serge Uzan 1.4k 0.9× 891 0.6× 1.2k 0.9× 1.0k 1.4× 409 0.6× 118 5.3k
Joseph A. Kuhn 1.7k 1.1× 1.6k 1.2× 2.4k 1.8× 1.4k 1.9× 597 0.8× 96 5.4k
Don R. Goffinet 730 0.5× 1.8k 1.3× 2.3k 1.7× 705 0.9× 1.4k 2.0× 127 5.2k
Mahmut Özsahin 854 0.6× 2.3k 1.6× 2.7k 2.0× 929 1.2× 2.1k 2.9× 149 6.9k
William J. Fulp 786 0.5× 1.8k 1.3× 1.1k 0.8× 245 0.3× 1.0k 1.4× 142 4.5k
Timothy J. Eberlein 1.9k 1.3× 4.0k 2.9× 1.4k 1.0× 1.4k 1.8× 959 1.3× 190 8.5k
Ki Chang Keum 550 0.4× 1.4k 1.0× 1.4k 1.0× 351 0.5× 792 1.1× 167 3.5k
A. A. M. Hart 536 0.4× 1.5k 1.1× 940 0.7× 622 0.8× 1.1k 1.6× 100 4.0k

Countries citing papers authored by D.A.L. Morgan

Since Specialization
Citations

This map shows the geographic impact of D.A.L. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.A.L. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.A.L. Morgan more than expected).

Fields of papers citing papers by D.A.L. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.A.L. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.A.L. Morgan. The network helps show where D.A.L. Morgan may publish in the future.

Co-authorship network of co-authors of D.A.L. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of D.A.L. Morgan. A scholar is included among the top collaborators of D.A.L. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.A.L. Morgan. D.A.L. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collins, Karen, et al.. (2017). 4th Symposium on Primary Breast Cancer in Older Women. Future Oncology. 13(sup8). 1–23.
2.
Toss, Michael S., Sarah E. Pinder, Andrew R. Green, et al.. (2016). Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins?. Histopathology. 70(5). 681–692. 13 indexed citations
3.
Mathew, John, et al.. (2016). Factors influencing local control in patients undergoing breast conservation surgery for ductal carcinoma in situ. The Breast. 31. 181–185. 5 indexed citations
4.
Grover, Surbhi, Manjeet Chadha, Ramesh Rengan, et al.. (2015). Education and Training Needs in Radiation Oncology in India: Opportunities for Indo–US Collaborations. International Journal of Radiation Oncology*Biology*Physics. 93(5). 957–960. 3 indexed citations
5.
Morgan, D.A.L.. (2014). Can Folding a Product Foster Emotional Attachment. 456–460. 1 indexed citations
6.
Syed, Binafsha Manzoor, Andrew R. Green, Christopher C. Nolan, et al.. (2014). Biological Characteristics and Clinical Outcome of Triple Negative Primary Breast Cancer in Older Women – Comparison with Their Younger Counterparts. PLoS ONE. 9(7). e100573–e100573. 32 indexed citations
7.
Syed, Binafsha Manzoor, Simon J. Johnston, Andrew R. Green, et al.. (2011). Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic. Annals of Oncology. 23(6). 1465–1471. 24 indexed citations
8.
Okunade, Gbolahan W., Andrew R. Green, Michael Ying, et al.. (2009). Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy. Critical Reviews in Oncology/Hematology. 72(1). 76–82. 9 indexed citations
9.
Morgan, D.A.L., et al.. (2002). Postoperative radiotherapy following mastectomy for high-risk breast cancer. European Journal of Cancer. 38(8). 1107–1110. 7 indexed citations
10.
Morgan, D.A.L., et al.. (2000). Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial. The Lancet. 356(9229). 540–544. 84 indexed citations
11.
Al‐Ghazal, SK, RW Blamey, John F. Stewart, & D.A.L. Morgan. (1999). The cosmetic outcome in early breast cancer treated with breast conservation. European Journal of Surgical Oncology. 25(6). 566–570. 115 indexed citations
12.
Morgan, D.A.L.. (1998). Setting Up Wound Dressing Guidelines: Avoiding The Pitfalls.. Journal of Tissue Viability. 8(3). 5–8. 4 indexed citations
13.
Morgan, D.A.L., et al.. (1997). A comparison of late cosmetic results following two different radiotherapy techniques for treating basal cell carcinoma. Clinical Oncology. 9(6). 400–402. 12 indexed citations
14.
Bleehen, N M, DJ Girling, A. Gregor, et al.. (1994). Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status?. British Journal of Cancer. 70(1). 142–144. 1 indexed citations
15.
Perkins, Alan C., et al.. (1993). Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations. British Journal of Cancer. 67(6). 1391–1394. 3 indexed citations
16.
Clark, Louise, et al.. (1991). Squamous carcinoma of the temporal bone: a revised staging. The Journal of Laryngology & Otology. 105(5). 346–348. 34 indexed citations
17.
MacLennan, Kenneth, et al.. (1989). Non-Hodgkin's lymphoma of the larynx (Stage IE). Cancer. 64(5). 1123–1127. 28 indexed citations
18.
Morgan, D.A.L., et al.. (1988). Vocal quality 10 years after radiotherapy for early glottic cancer. Clinical Radiology. 39(3). 295–296. 30 indexed citations
19.
Morgan, D.A.L.. (1986). Efficacy and tolerability of vindesine in the treatment of small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 18(2). 172–3. 3 indexed citations
20.
Morgan, D.A.L., Ronald F. Young, Anthony W. Chow, Mark Mehringer, & Hideo H. Itabashi. (1979). Recurrent Intracerebral Blastomycotic Granuloma. Neurosurgery. 4(4). 319–324. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026